Literature DB >> 7447355

A recommended scheme for the evaluation of kits in the clinical laboratory.

I W Percy-Robb, P M Broughton, R D Jennings, J J McCormack, D W Neill, R A Saunders, M Warner.   

Abstract

A scheme for kit evaluation in the individual clinical chemistry laboratory is presented. Recommendations for assessing accuracy, precision, and stability are included along with a scheme for preparing for the evaluation and writing the final report.

Mesh：

Substances：

Year:  1980        PMID： 7447355     DOI： 10.1177/000456328001700501

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN： 0004-5632            Impact factor:   2.057


  4 in total

1.  Multicenter evaluation of five commercial rubella virus immunoglobulin G kits which report in international units per milliliter.

Authors:  W Dimech; A Bettoli; D Eckert; B Francis; J Hamblin; T Kerr; C Ryan; I Skurrie
Journal:  J Clin Microbiol       Date:  1992-03       Impact factor: 5.948

2.  Use of Deming regression in method-comparison studies.

Authors:  H Konings
Journal:  Surv Immunol Res       Date:  1982

3.  Guidelines for the evaluation of instruments used in haematology laboratories.

Authors:  N K Shinton; J M England; D A Kennedy
Journal:  J Clin Pathol       Date:  1982-10       Impact factor: 3.411

4.  Colorimetric enzymatic measurement of serum total 3 alpha-hydroxy bile acid concentrations without extraction.

Authors:  M Y Qureshi; S M Smith; G M Murphy
Journal:  J Clin Pathol       Date:  1984-03       Impact factor: 3.411
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.